Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness

Overview of attention for article published in Journal of Translational Medicine, September 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 7 X users

Readers on

mendeley: 38 Mendeley

Summary X

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 30,308 followers.

RT @Dibiomec: Published in 2019, @Dibiomec demonstrated differences in correlations between variables across individuals showing differenti…

05 Nov 2021

Reply Repost Favourite

Published in 2019, @Dibiomec demonstrated differences in correlations between variables across individuals showing differential ISUP GG prostate cancer risk. You can read the full text at the following link: https://t.co/lMQ3f42Faw https://t.co/oLY61AZh3U

03 Nov 2021

Reply Repost Favourite

RT @hjoan23: 🗞️#Bondia l'@hjoan23publica a #JTranslMed @BioMedCentral 🔬 Biofluid quantification of TWEAK/Fn14 axis in combination with a se…

05 Aug 2020

Reply Repost Favourite

RT @hjoan23: 🗞️#Bondia l'@hjoan23publica a #JTranslMed @BioMedCentral 🔬 Biofluid quantification of TWEAK/Fn14 axis in combination with a se…

05 Aug 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.